Get Retatrutide Online in New Hampshire | OmniRx Health
Medical Weight Loss Treatment in New Hampshire
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Key Benefits
- Triple receptor mechanism: GLP-1 + GIP + glucagon for amplified metabolic effect
- Phase 2 data shows 24.2% average weight loss at 48 weeks (12mg dose)
- ~58% hepatic fat reduction in Phase 2 sub-group analyses
- Elevated basal metabolic rate via glucagon receptor agonism
- Research-grade purity ≥98% with full CoA, HPLC, and MS documentation
Who is a Good Candidate?
Intended for laboratory researchers and pre-clinical study investigators studying triple receptor agonism, obesity mechanisms, hepatic metabolism, or GLP/GIP/glucagon signaling pathways. Listed for research-use only (RUO) — not for human therapeutic use.
Available for research use
Serving New Hampshire
New Hampshire embodies independence—and that includes healthcare choices. From the tech corridor of Manchester to the ski towns of the White Mountains, the seacoast communities to the lakes region, OmniRx Health serves the entire Granite State. Our telehealth platform respects your time and privacy, providing expert care without the need to navigate winter roads or wait in crowded waiting rooms. Live free, live healthy, with convenient virtual care.
Our providers are licensed by the New Hampshire Board of Medicine to deliver telehealth throughout the Granite State.
New Hampshire pharmacies in Manchester, Nashua, Concord, and northern communities provide prescription services with statewide delivery.
New Hampshire has telehealth laws that balance provider flexibility with patient protection, supporting virtual care across the state.
New Hampshire insurers cover telehealth services, making virtual care accessible for residents throughout the state.
Frequently Asked Questions
- What is retatrutide and how does it work?
- Retatrutide (CAS 2381089-83-2) is a 39-amino acid synthetic peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This triple agonism produces coordinated appetite suppression (GLP-1), amplified insulin and fat-cell metabolism (GIP), and increased hepatic glucose output and resting energy expenditure (glucagon). It is currently in Phase 3 clinical trials and is available for research-use only (RUO).
- How does retatrutide compare to semaglutide and tirzepatide in research?
- Phase 2 data (NEJM, 2023) showed retatrutide at 12mg produced 24.2% average weight loss at 48 weeks, outperforming semaglutide (~15% at 68 weeks) and tirzepatide (~22% at 72 weeks) in their respective trials. Retatrutide adds glucagon receptor agonism — absent in both comparators — which appears to drive additional metabolic rate elevation and hepatic fat clearance.
- Is retatrutide available for human use?
- No. Retatrutide has not received FDA approval for any human therapeutic use. It is currently in Phase 3 (TRIUMPH) clinical trials and is listed by OmniRx strictly as a research-use only (RUO) compound for laboratory and pre-clinical research applications.
- Is telehealth legal in New Hampshire?
- Yes, telehealth is legal in New Hampshire. The state supports virtual healthcare delivery, allowing licensed providers to offer consultations, prescriptions, and ongoing care remotely.
- Can White Mountains residents use telehealth?
- Telehealth is ideal for New Hampshire's mountain communities, where winter weather and distance can make in-person visits challenging. Our platform brings care to you.
- Does New Hampshire insurance cover telehealth?
- Most New Hampshire health insurance plans cover telehealth visits. Coverage varies by plan, but virtual care is widely recognized as a standard care delivery method.